Jeffrey W. Clark
Impact in
- Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 170
- Pancreatic and Hepatic Oncology Research 67
- Colorectal Cancer Treatments and Studies 49
-
- Lung Cancer Treatments and Mutations 34
- Gastric Cancer Management and Outcomes 25
- Co-authors
- David P. Ryan (148 shared papers)Dan G. Duda (19 shared papers)Charles S. Fuchs (42 shared papers)Eunice L. Kwak (54 shared papers)Peter C. Enzinger (35 shared papers)Lawrence S. Blaszkowsky (87 shared papers)Andrew X. Zhu (69 shared papers)Jay S. Loeffler (1 shared paper)
- Journals
- Journal of Clinical Oncology (86 papers)Cancer (23 papers)International Journal of Radiation Oncology*Biology*Physics (15 papers)The Oncologist (12 papers)Clinical Cancer Research (12 papers)
- Partner nations
- United StatesItalySouth Korea
In The Last Decade
Jeffrey W. Clark
340 papers receiving 17.6k citations
Jeffrey W. Clark's Hit Papers
Peers
Comparison fields: 5 of 167
- Oncology 6.5k
- Hepatology 1.7k
- Cancer Research 2.4k
- Pulmonary and Respiratory Medicine 3.8k
- Pathology and Forensic Medicine 1.8k
Countries citing papers authored by Jeffrey W. Clark
This map shows the geographic impact of Jeffrey W. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey W. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey W. Clark more than expected).
Fields of papers citing papers by Jeffrey W. Clark
This network shows the impact of papers produced by Jeffrey W. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey W. Clark. The network helps show where Jeffrey W. Clark may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey W. Clark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 363 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lessons from phase III clinical trials on anti-VEGF therapy for cancer Hit paper breakdown → | 2006 | 882 |
| 2 | Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor Hit paper breakdown → | 2010 | 640 |
| 3 | Frequent Mutation of Isocitrate Dehydrogenase(IDH)1andIDH2in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping Hit paper breakdown → | 2011 | 571 |
| 4 | Quality of informed consent in cancer clinical trials: a cross-sectional survey Hit paper breakdown → | 2001 | 516 |
| 5 | 2006 | 411 | |
| 6 | 2009 | 409 | |
| 7 | Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001 Hit paper breakdown → | 2019 | 379 |
| 8 | 2009 | 375 | |
| 9 | Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma Hit paper breakdown → | 2018 | 373 |
| 10 | 2007 | 360 | |
| 11 | 2011 | 360 | |
| 12 | 2011 | 351 | |
| 13 | 2006 | 320 | |
| 14 | 2001 | 316 | |
| 15 | 2005 | 303 | |
| 16 | 2008 | 301 | |
| 17 | 2010 | 290 | |
| 18 | 2008 | 252 | |
| 19 | 2017 | 241 | |
| 20 | 2009 | 239 |
About Jeffrey W. Clark
Jeffrey W. Clark is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Immunology and Cancer Research, having authored 363 papers that have together received 18.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (67 papers), Colorectal Cancer Treatments and Studies (49 papers), Lung Cancer Treatments and Mutations (34 papers), Cancer Genomics and Diagnostics (31 papers), Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Gastric Cancer Management and Outcomes (25 papers), Neuroendocrine Tumor Research Advances (23 papers) and T-cell and Retrovirus Studies (21 papers). The work is most often cited by research in Oncology (6.5k citations), Hepatology (1.7k citations), Cancer Research (2.4k citations), Pulmonary and Respiratory Medicine (3.8k citations) and Pathology and Forensic Medicine (1.8k citations). Jeffrey W. Clark has collaborated with scholars based in United States, Italy and South Korea. Frequent co-authors include David P. Ryan, Dan G. Duda, Charles S. Fuchs, Eunice L. Kwak, Peter C. Enzinger, Lawrence S. Blaszkowsky, Andrew X. Zhu, Jay S. Loeffler, Matthew H. Kulke and Jeffrey A. Meyerhardt. Their work appears in journals such as Journal of Clinical Oncology, Cancer, International Journal of Radiation Oncology*Biology*Physics, The Oncologist and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.